Consensus and differences in primary radiotherapy for localized and locally advanced prostate cancer in Switzerland-Reference-Cited by-同舟云学术

Consensus and differences in primary radiotherapy for localized and locally advanced prostate cancer in Switzerland

Published:2015-05-19 Issue:10 Volume:191 Page:778-786
ISSN:0179-7158
Container-title:Strahlentherapie und Onkologie
language:en
Short-container-title:Strahlenther Onkol

Author:

Panje Cédric M.,Dal Pra Alan,Zilli Thomas,R. Zwahlen Daniel,Papachristofilou Alexandros,Herrera Fernanda G.,Matzinger Oscar,Plasswilm Ludwig,Putora Paul Martin

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Radiology, Nuclear Medicine and imaging

Link

http://link.springer.com/content/pdf/10.1007/s00066-015-0849-8.pdf

Reference40 articles.

1. Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics, 2014. CA Cancer J Clin 64:9–29. doi:10.3322/caac.21208

2. Wenz F, Martin T, Bohmer D, Martens S, Sedlmayer F, Wirth M, Miller K, Heidenreich A, Schrader M, Hinkelbein W, Wiegel T (2010) The German S3 guideline prostate cancer: aspects for the radiation oncologist. Strahlenther Onkol 186:531–534. doi:10.1007/s00066-010-2193-3

3. Mohler JL, Kantoff PW, Armstrong AJ, Bahnson RR, Cohen M, D’Amico AV, Eastham JA, Enke CA, Farrington TA, Higano CS, Horwitz EM, Kane CJ, Kawachi MH, Kuettel M, Kuzel TM, Lee RJ, Malcolm AW, Miller D, Plimack ER, Pow-Sang JM, Raben D, Richey S, Roach M, III, Rohren E, Rosenfeld S, Schaeffer E, Small EJ, Sonpavde G, Srinivas S, Stein C, Strope SA, Tward J, Shead DA, Ho M (2014) Prostate cancer, version 2.2014. J Natl Compr Cancer Netw 12:686–718

4. Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, van der Kwast T, Mason M, Matveev V, Wiegel T, Zattoni F, Mottet N (2014) EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013. Eur Urol 65:124–137. doi:10.1016/j.eururo.2013.09.046

5. Bolla M, de Reijke TM, Van Tienhoven G, Van den Bergh AC, Oddens J, Poortmans PM, Gez E, Kil P, Akdas A, Soete G, Kariakine O, van der Steen-Banasik EM, Musat E, Pierart M, Mauer ME, Collette L, Group ERO, genito-urinary tract cancer G (2009) Duration of androgen suppression in the treatment of prostate cancer. N Engl J Med 360:2516–2527. doi:10.1056/NEJMoa0810095

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Variations in Radioiodine Therapy in Europe: Decision-Making after Total Thyroidectomy;Oncology;2021-11-17

2. PROSTAT KANSERİNDE PELVİK YOĞUNLUK AYARLI RADYASYON TEDAVİSİ VE EŞ ZAMANLI EK DOZ TEDAVİ PLANLAMALARINDA DOZİMETRİK PARAMETRELERİN DEĞERLENDİRİLMESİ;Kocatepe Tıp Dergisi;2021-04-04

3. Variations in radioiodine ablation: decision-making after total thyroidectomy;European Journal of Nuclear Medicine and Molecular Imaging;2019-11-09

4. Radiotherapy for pelvic nodal recurrences after radical prostatectomy: patient selection in clinical practice;Radiation Oncology;2019-10-16

5. Treatment Options in Oncology;JCO Clinical Cancer Informatics;2018-12